Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

chugai-pharm.co.jp

Chugai Pharmaceutical: News Releases

Get the latest updates from Chugai Pharmaceutical: News Releases directly as they happen.

Follow now 164 followers

Latest posts

Last updated 6 days ago

Chugai Files for Additional Tumor-Agnostic Indication of Alecensa for ALK Fusion / Rearrangement Gene-Positive Solid Tumors Including Pediatric Patients

6 days ago

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-1 for Type 2 Diabetes Published in The New England Journal of Medicine)

9 days ago

Phase I/II Study in Hemophilia A Suggests NXT007 May Have the Potential to Provide Hemostatic Normalization

9 days ago

Roche Announces Global Phase III SUNMO Study Data for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (Combination Therapy with Lunsumio and Polivy)

9 days ago

Roche Announces New Safety Information of Elevidys for Non-Ambulatory Duchenne Muscular Dystrophy

16 days ago

Galderma’s Announcement Regarding NEMLUVIO (New Long Term Data Presentation in Atopic Dermatitis)

23 days ago

Verastem Oncology’s Announcement Regarding AVMAPKI (Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma)

about 1 month ago

Positive Results from Phase III TALENTACE Study of Tecentriq and Avastin for Unresectable Hepatocellular Carcinoma

about 1 month ago

Chugai Obtains First Regulatory Approval in Japan for Vabysmo for Additional Indication of Angioid Streaks, a Cause of Vision Loss

about 1 month ago

PiaSky Approved in Taiwan as First Subcutaneous Treatment for Paroxysmal Nocturnal Hemoglobinuria

about 1 month ago

Chugai Files for Additional Indication of Tecentriq for the Treatment of Thymic Carcinoma

about 2 months ago

Chugai Receives Regulatory Approval for “ELEVIDYS” as a Gene Therapy Product for Duchenne Muscular Dystrophy in Japan

about 2 months ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now